These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7694311)

  • 21. Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy.
    Tomaszewski JJ; Chen YF; Bertolet M; Ristau BT; Woldemichael E; Nelson JB
    Urology; 2013 May; 81(5):992-6. PubMed ID: 23453649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residual prostatic tumour in the surgical bed following radical prostatectomy in organ-confined prostate cancer: possible prognostic significance.
    Valotto C; Falconieri G; Pizzolitto S; Cerruto MA; Brondani G; De Gobbi A; Zattoni F
    Arch Ital Urol Androl; 2011 Jun; 83(2):78-82. PubMed ID: 21826879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Echographic follow-up after radical prostatectomy].
    Rosi P; Valli PP; Petroni PA; Morcellini R; Bracarda S; Porena M
    Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):43-8. PubMed ID: 9162372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?
    Koppie TM; Grossfeld GD; Nudell DM; Weinberg VK; Carroll PR
    J Urol; 2001 Jul; 166(1):111-5. PubMed ID: 11435834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging.
    Liauw SL; Pitroda SP; Eggener SE; Stadler WM; Pelizzari CA; Vannier MW; Oto A
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):378-84. PubMed ID: 22717242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postradical prostatectomy TRUS-guided anastomotic biopsy. Where do we stand today?
    Anagnostou T; Doumas K; Remzi M; Djavan B
    Prostate Cancer Prostatic Dis; 2004; 7(4):302-10. PubMed ID: 15278096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The accuracy of transrectal ultrasound prostate volume estimation: clinical correlations.
    Matthews GJ; Motta J; Fracehia JA
    J Clin Ultrasound; 1996; 24(9):501-5. PubMed ID: 8906481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of patient age on biochemical recurrence rates following radical prostatectomy.
    Magheli A; Rais-Bahrami S; Humphreys EB; Peck HJ; Trock BJ; Gonzalgo ML
    J Urol; 2007 Nov; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy.
    Soergel TM; Koch MO; Foster RS; Bihrle R; Wahle G; Gardner T; Jung SH
    J Urol; 2001 Dec; 166(6):2198-201. PubMed ID: 11696735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.
    Parivar F; Hricak H; Shinohara K; Kurhanewicz J; Vigneron DB; Nelson SJ; Carroll PR
    Urology; 1996 Oct; 48(4):594-9. PubMed ID: 8886066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological characteristics of prostate cancer recurrence after radiation therapy: implications for focal salvage therapy.
    Leibovici D; Chiong E; Pisters LL; Guo CC; Ward JF; Andino L; Prokhorova IN; Troncoso P
    J Urol; 2012 Jul; 188(1):98-102. PubMed ID: 22578724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computed tomography appearance of the prostatic fossa following radical prostatectomy.
    Older RA; Lippert MC; Gay SB; Omary RA; Hillman BJ
    Acad Radiol; 1995 Jun; 2(6):470-4. PubMed ID: 9419593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
    Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of endorectal MR imaging to predict prostate carcinoma recurrence after radical prostatectomy.
    Manzone TA; Malkowicz SB; Tomaszewski JE; Schnall MD; Langlotz CP
    Radiology; 1998 Nov; 209(2):537-42. PubMed ID: 9807586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staging of prostate cancer. Accuracy of transrectal ultrasound enhanced by prostate-specific antigen.
    Wolf JS; Shinohara K; Narayan P
    Br J Urol; 1992 Nov; 70(5):534-41. PubMed ID: 1281724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
    Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
    Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
    Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
    J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
    Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
    J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.